Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus
about
Epidemiological and Clinical Features of Severe Fever with Thrombocytopenia Syndrome in Japan, 2013-2014.Modeling Severe Fever with Thrombocytopenia Syndrome Virus Infection in Golden Syrian Hamsters: Importance of STAT2 in Preventing Disease and Effective Treatment with FavipiravirSevere Fever with Thrombocytopenia Syndrome in South Korea, 2013-2015Animal Models of Emerging Tick-Borne Phleboviruses: Determining Target Cells in a Lethal Model of SFTSV InfectionHemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.Extinction of West Nile virus by Favipiravir through lethal mutagenesis.An Overview of Animal Models for Arthropod-Borne Viruses.Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravir.Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitors.Epidemiology of severe fever and thrombocytopenia syndrome virus infection and the need for therapeutics for the prevention.Favipiravir (T-705) protects against Nipah virus infection in the hamster model.
P2860
Q33436263-811F6BB5-C876-4123-B236-711965D956DFQ33437038-A67E8B67-AEBF-487A-A7EB-E246BDFF2436Q33437970-2273C242-9CBC-45CF-B519-3AFEEFC05F12Q33439301-6F782694-FDB3-4983-ACF1-485E557CABFCQ33439713-282F2AB7-7AB9-41E8-A5BB-73BC4AA1A702Q38605122-152EAEBD-7341-4CED-85CA-E4E8C1A478DFQ38664968-0FF7AF03-8984-4C9C-AD33-0F50615C97A3Q40040920-5609DC08-4D8D-4199-815A-716C98AB7615Q40044875-439A157F-5532-410D-81F7-C0B4F1FBA88CQ45325372-57D494C7-801B-46CE-9350-C19CFC6B6628Q48109117-3E044509-8B61-47E5-889A-8284E437E6CAQ54989893-BD22BC5F-894E-49C6-959A-A90FA082FC08
P2860
Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Efficacy of T-705 (Favipiravir ...... hrombocytopenia Syndrome Virus
@ast
Efficacy of T-705 (Favipiravir ...... hrombocytopenia Syndrome Virus
@en
type
label
Efficacy of T-705 (Favipiravir ...... hrombocytopenia Syndrome Virus
@ast
Efficacy of T-705 (Favipiravir ...... hrombocytopenia Syndrome Virus
@en
prefLabel
Efficacy of T-705 (Favipiravir ...... hrombocytopenia Syndrome Virus
@ast
Efficacy of T-705 (Favipiravir ...... hrombocytopenia Syndrome Virus
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Efficacy of T-705 (Favipiravir ...... hrombocytopenia Syndrome Virus
@en
P2093
Aiko Fukuma
Akihiko Uda
Haruo Watanabe
Hideki Hasegawa
Hideki Tani
Masayuki Saijo
Masayuki Shimojima
Naoko Iwata-Yoshikawa
Noriyo Nagata
Satoshi Taniguchi
P2860
P356
10.1128/MSPHERE.00061-15
P577
2016-01-06T00:00:00Z